BioWednesday: Creating and Defending Sustainable Value in Life Science IP
****Registration for this event is now closed, for registration enquiries please email email@example.com****
In association with Fish & Richardson. IP due diligence requires skilled IP counsel to advise on how to be compliant and how best to avoid falling foul of the implications if you do fall short and is vital to the success of sustained value creation. A vital goal of those in technology transfer, business development and investment roles if they are to base deals upon their IP and survive due diligence.
Mike Ward, Global Head of Life Sciences and Healthcare Thought Leadership, Clarivate
Chad Shear, Principal, Fish & Richardson
Emma Hodge, Small Pharma
Michael Murray, Murray International Partners Limited
By way of setting the scene you may want to check out the Scrip/Fish& Richardson Intellectual Property Sourcebook